Researchers used green tea extract to control the generation of metal-associated beta amyloid aggregates associated with Alzheimer's disease. Above is a histopathogic image of senile plaques seen in the cerebral cortex in a patient with presenile onset of Alzheimer disease. Credited to KGH.
Researchers at the University of Michigan have found a new potential benefit of a molecule in green tea: preventing the misfolding of specific proteins in the brain.
The aggregation of these proteins, called metal-associated amyloids, is associated with Alzheimer’s disease and other neurodegenerative conditions.
A paper published recently in the Proceedings of the National Academy of Sciences explained how U-M Life Sciences Institute faculty member Mi Hee Lim and an interdisciplinary team of researchers used green tea extract to control the generation of metal-associated amyloid-β aggregates associated with Alzheimer’s disease in the lab.
The specific molecule in green tea, (—)-epigallocatechin-3-gallate, also known as EGCG, prevented aggregate formation and broke down existing aggregate structures in the proteins that contained metals—specifically copper, iron and zinc.
“A lot of people are very excited about this molecule,” said Lim, noting that the EGCG and other flavonoids in natural products have long been established as powerful antioxidants. “We used a multidisciplinary approach. This is the first example of structure-centric, multidisciplinary investigations by three principal investigators with three different areas of expertise.”
The research team included chemists, biochemists and biophysicists.
While many researchers are investigating small molecules and metal-associated amyloids, most are looking from a limited perspective, said Lim, assistant professor of chemistry and research assistant professor at the Life Sciences Institute, where her lab is located and her research is conducted.
“But we believe you have to have a lot of approaches working together, because the brain is very complex,” she said.
The PNAS paper was a starting point, Lim said, and her team’s next step is to “tweak” the molecule and then test its ability to interfere with plaque formation in fruit flies.
“We want to modify them for the brain, specifically to interfere with the plaques associated with Alzheimer’s,” she said.
Lim plans to collaborate with Bing Ye, a neurobiologist in the LSI. Together, the researchers will test the new molecule’s power to inhibit potential toxicity of aggregates containing proteins and metals in fruit flies.
Notes about this Alzheimer’s disease research
Other authors of the paper, all from U-M, are: Sanghyun Lee and Jung-Suk Choi of the Life Sciences Institute; Alaina DeToma, Suk-Joon Hyung, Akiko Kochi and Brandon Ruotoloa of the Department of Chemistry; and Jeffrey Brender, Ayyalusamy Ramamoorthy and Subramanian Vivekanandan of the Department of Chemistry and Biophysics.
The work was supported by the National Institutes of Health, Alzheimer’s Association, Alzheimer’s Art Quilt Initiative, American Heart Association, and a Graduate Research Fellowship from the National Science Foundation Study.
Contact: Laura J. Williams – University of Michigan Source:University of Michigan press release Image Source: Image credited to KGH at Wikimedia Commons and licensed as Creative Commons Attribution-Share Alike 3.0 Unported. Original Research:Abstract for “Insights into antiamyloidogenic properties of the green tea extract (−)-epigallocatechin-3-gallate toward metal-associated amyloid-β species” by Suk-Joon Hyung, Alaina S. DeToma, Jeffrey R. Brender, Sanghyun Lee, Subramanian Vivekanandan, Akiko Kochi, Jung-Suk Choi, Ayyalusamy Ramamoorthy, Brandon T. Ruotolo and Mi Hee Lima in Proceedings of the National Academy of Sciences. Published online March 5 2013 doi: 10.1073/pnas.1220326110